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ABSTRACT
Purpose: This study explores the potential of the simvastatin to ameliorate inflammation and infection in open infected
skin wounds of rats. Methods: Fourteen Wistar rats weighing  285±12g were used. The study was done in a group whose
open infected skin wounds were treated with topical application of sinvastatina microemulsion (SIM, n=7) and a second
group with wounds treated with saline 0.9 % (SAL, n=7). A bacteriological exam of the wounds fluid for gram positive and
gram negative bacteria, the tecidual expression of TNFá and  IL-1â by imunohistochemical technique, and histological
analysis by HE stain were performed. Results: The expression of TNFa could be clearly demonstrated in lower degree in
skin wounds treated with simvastatin (668.6 ± 74.7 ìm2) than in saline (2120.0 ± 327.1 ìm2). In comparison, wound tissue from
SIM group displayed leukocyte infiltration significantly lower than that observed in SAL group (p<0.05). Culture results
of the samples taken from wound fluid on fourth post treatment day revealed wound infection in only one rat of group
simvastatin (SIM), where Proteus mirabilis, Escherchia coli and Enterobacter sp were isolated. In the rats whose wounds
were treated with saline (SAL), polymicrobial infection with more than 100,000 CFU/g was detected in all the wounds.
Conclusion: In addition to its antiinflammatory properties, the protective effects of simvastatin in infected open skin
wounds is able to reduce infection and probably has antibacterial action. The potential to treat these wounds with statins
to ameliorate inflammation and infection is promising.
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RESUMO:
Objetivo: O presente estudo avaliou o potencial da sinvastatina para atenuar a inflamação e a infecção em feridas abertas
infectadas de pele de  ratos. Métodos: Foram utilizados 14 ratos Wistar pesando 285±12g. O estudo foi realizado com um
grupo de animais cujas feridas abertas infectadas foram tratadas com aplicação tópica de sinvastatina  microemulsão (SIM,
n=7) e um segundo grupo com feridas tratadas com solução salina 0,9% (SAL n=7). Foi realizado exame bacteriológico do
fluido das feridas para detecção de bactérias gram positivas e negativas, a expressão tecidual de TNFá e IL-1â por
imunohistoquímica e análise histológica pela coloração H-E.  Resultados: A expressão do TNFa pode ser claramente
demonstrada em menor grau  nas feridas de pele tratadas com sinvastatina (668.6 ± 74.7 ìm2) do que no grupo salina (2120.0
± 327.1 ìm2). Em comparação, os tecidos das feridas do grupo SIM mostrou infiltração leucocitária significantemente menor
do que a observada no grupo  SAL  (p<0,05). O resultado das culturas realizadas no fluido das feridas no 4º dia de
tratamento revelou infecção em apenas um rato do grupo sinvastatina (SIM), onde Proteus mirabilis, Escherchia coli e
Enterobacter sp foram isolados. Nos ratos cujas feridas foram tratadas com solução salina (SAL), infecção polimicrobiana
com mais de 100,000 UFC/g foi detectada em todas as feridas. Conclusão: Além de suas propriedades antiinflamatórias, o
efeito protetor da sinvastatina em feridas abertas e infectadas de pele é capaz de reduzir a infecção e provavelmente tem
ação antibacteriana. O potencial da droga para atenuar inflamação e infecção de feridas é promissor.
Descritores: Estatinas. Inflamação. Cicatrização de Feridas. Rato Wistar. Pele. Citocinas.
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Introduction
The healing of open skin wounds involves the
epithelium and underlying stroma. Processes such as
angiogenesis, activation, migration, and proliferation of
fibroblasts, myofibroblasts and endothelial cells;
formation of granulation tissue; and wound contraction
are needed to close these defects1,2. Some wounds are
also frequently inflamed and, in general, stromal
involvement and inflammation greatly increase the risk
of subsequent complications3,4 The repair process begins
immediately after injury by the release of various growth
factors, cytokines, and low-molecular weight compounds.
Disruption of blood vessels also leads to the formation
of the blood clot, which is composed of cross-linked
fibrin, and of extracellular matrix proteins such as
fibronectin, tenascin, and thrombospondin5 . Wound
infection develops in 2% to 5% of patients undergoing
surgical procedures each year in most hospitals world-
wide and continues being considered one of the most
important problems in surgical wards nowadays. It is one
of the main factors that alter the physiologic evolution
of the wound healing6,7 The bacteria inhibit the
angiogenesis, secrete plasminogen activators, and
proteolitic enzymes that may affect the extracelular matrix,
blocking the wound contraction8 Several substances have
been used to treat infected skin wounds, like honey,
sugar, antibiotics, phytotherapics9,10,11,12,13 Statins are a
class of compounds that competitively inhibit the enzyme
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)
reductase, the first committed step in cholesterol
biosynthesis. Increasingly, the pleiotropic properties of
statins are being described. In endothelial cells, all of
these effects seem to result from the inhibition of
cholesterol’s precursor mevalonic acid, which is critical
to the isoprenylation of a diverse family of proteins14,15.
Simvastatin, a HMG-CoA reductase inhibitor, have been
shown to exhibit important immunomodulatory effects
independent of lipid lowering16. These pleiotropic effects
have been demonstrated to include anti-inflammatory
actions17. improvement of endothelial and microvascular
function, modulation of endothelial nitric oxide synthase
(eNOS)18,  ischemia/reperfusion19  and sepsis20 . However,
statins have not been used to treat skin infected wounds.
We thus approached the question of whether topical
treatment with simvastatin might improve the healing of
skin infected wounds in a rat model.
Methods
The experimental protocol was approved by the
Research Ethics Committee (Animal Research Ethics
Division) of the University Hospital-UFRN, Brazil.
Animals were handled in accordance with the Guide for
the Care and Use of Laboratory Animals, Brazilian College
of Animal Experimentation.
Animals
Wistar rats (Rattus norvegicus albinus, Rodentia
mammalia) weighing 282???g were used. They were
housed in polypropilene cages and maintained under
controlled temperature conditions on a 12h light-dark
cycle and allowed ad libitum access to commercially
available rat chow (Labina, Purina®) and water.
Experimental design and procedures
The animals were randomly separated in two groups
of seven rats each. After 12 hours of fasting, the rats were
anesthetized by intramuscular injection of 30mg/Kg of
ketamine and thiopental 20mg/Kg intraperitoneal. After
dorsal skin depilation and anti-sepsis with 1% povidona,
the surgical procedures were performed under aseptic
conditions. An open skin squared wound (1cm2), was done
in the dorsal skin of all the rats. Immediately after the surgical
procedure, the wounds were contaminated with topical
application of 0.5mL of multibacterial solution prepared with
1g of rats fresh feces and 10mL of saline. In the following
day, the infected wounds of the simvastatin group (SIM)
(n=7) were topically treated with 0.2 ml of simvastatin
microemulsion (10mg/mL) once a day. The wounds of group
saline (SAL) (n=7) rats were treated with 0.2 ml of saline
solution daily. When the wounds were totally epithelialized,
the healing time was recorded and the resection of the scar
was performed under anesthesia. The healed tissues were
used for histopathological study and immunohistochemical
dosage of tumor necrosis factor-α (TNF-α) and interleukine-
1 (IL-1β).
Immunohistochemical staining of TNF-α and IL-1β.
Immunohistochemical staining for TNF-α and IL-1β
was performed on tissue samples obtained from the
healing skin. These samples were fixed in 4%
paraformaldehyde, processed in routine technique, cut
into 5mm-thick frozen sections, and dried at room
temperature. Absolute methanol containing 3% hydrogen
peroxide was added to block endogenous peroxidase.
After three washings with a phosphate-buffered solution
(PBS) for 5 min each, these sections were treated with
1% polyoxyethylene-10-octylphenyl ether in PBS for 20
min at room temperature. After washing in the same way,
these were reacted with 100 ml of biotinylated anti-rat
TNF-α monoclonal antibody (Pharmingen, San Diego, CA)
or biotinylated anti-rat IL-1β monoclonal antibody
(Pharmingen), diluted in 9 mL of PBS and 1 ml of whole
goat serum at room temperature in a moist chamber for 2
h. After washing, the preparations were incubated, with
two drops each of avidin solution and biotinylated
peroxidase solution in 4.5 ml of PBS and 0.5 ml of 5%
skim milk for 2 h at  37°C. After PBS rinsing,
diaminobenzidine and nickel were applied for 8 min to
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achieve permanent color change. Six views were selected
randomly for each section and observed under a light
microscope (x100). The mean number of reactive cells in
the six views was regarded as the data for each sample.
Sequential images of microscopic sections were
photographed within 72 hours after immunostaining, by
a digital camera (Sony, Tokyo, Japan) mounted on a light
microscope (Olympus B-50, Tokyo, Japan) at a
magnification of 100x, and saved in jpg file format. Images
were then analyzed in ImagePro-Plus software (Media
Cybernetics, LP, USA). Briefly, the entire area colored by
cytokines was marked, and the total marked area was
calculated. The area stained by the antibody of interest
was identified and calculated by using the software color
algorithm. The integrated optical areas stained by anti-
bodys were then recorded. The score index was
calculated for each of the antibodies and it was averaged.
Histopathology
The biopsies of skin wounds were processed
following the routine and stained with hematoxilin and
eosin (HE) for histological analysis of the inflammatory
reaction, using the optical microscope Olympus B-50,
Japan, Tokyo. The quantification of cells, fibers and
elements of the inflammatory reaction was performed by
the Image Pro-Plus Média Cybernetics software, LP, USA.
Bacteriological examination
At the 4th postoperative day, exsudato was collected
from the wounds for microbiology and for quantitation
of bacterial population. The materials were processed
and cultured on selective MacConkey’s agar, blood agar
and salt manitol agar. The agar plates were incubated at
37 oC and examined for growth after 24, 48 and 72 hours.
Any growth in the plates of bacteria of the same biotype
as cultured in the wounds was considered positive and
expressed as colony-forming units per gram of tissue
(CFU/g). All procedures were performed under laminar
air flux.
Statistical analysis
Data are presented as the mean±standard deviation.
Results were analyzed with ANOVA and Student t test.
Statistical significance was assumed at p< 0.05.
Results
Tumor necrosis factor alpha (TNFα)
The expression of TNFα  could be clearly
demonstrated in lower degree in skin wounds treated with
simvastatin (668.6 ± 74.7 ìm2) than in saline (2120.0 ± 327.1
ìm2) treated wounds, as can be shown in figure 1 and
table 1. So, a distinct decrease of tissue reactivity
occurred when the simvastatin microemulsion was
applied to the infected wounds.
FIGURE 1 - Mean areas corresponding to the expression of
TNFα Significant difference comparing the
groups simvastatin and saline (p<0.05).
TABLE 1 - Mean and statistical analysis of optical density
related to the expression of cytokines in
tissues of skin infected wounds treated with
simvastatin and saline (µm2).
Simvastatin Saline p-value
Cytokines (SIM)* (SAL)*
TNFα 668.6 ± 74.7 2120.0 ± 327.1 0.00001
IL-1β 467.6 ± 55.2 691.6 ± 67.4 0.00001
* Mean ± Standard deviation
1 – Difference statistically significant comparing the groups SIM/
SAL (Student t test).
Image Pro-plus software Media Cybernetics was used.
Groups
Interleukin-1b
IL-1b  expression was significantly more enhanced in
the saline (SAL) group than in the Simvastatin (SIM) group
after total epithelialization of the skin wounds. A clearly
decreased immunohistochemical stainability could be
noticed in the SIM group, whose data are expressed in figure
2 and table 1.
Histopathology
Contamination of skin wounds with multibacterial fecal
solution caused intense inflammatory reaction in tissues of
group SAL rats, with edema and marked leukocyte infiltration
consistent with acute injury (Figure 3). In comparison, wound
tissue from SIM group displayed leukocyte infiltration
significantly lower than that observed in SAL group. (p<0.05).
These pathologic changes were reduced by the administration
of simvastatin topically in the infected wounds (Table 2)  The
histological slides  (figures 3 and 4) suggest differences in
neutrophil accumulation between the SAL and SIM groups.
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Bacteriological examination
Culture results of the samples taken from wound
fluid on fourth post treatment day revealed wound
infection in only the rat number 4 of group simvastatin
(SIM), where Proteus mirabilis, Escherchia coli and
Enterobacter sp were isolated. In the rats whose wounds
were treated with saline (SAL), polymicrobial infection
with more than 100,000 CFU/g was detected in all the
wounds (Table 3). The most frequently isolated
microorganisms can be observed in table 3.
FIGURE 4 - Histological section of wound tissue taken from
SIM group rat, demonstrating low neutrophil
infiltration and good epithelial regeneration.
HE, 100x.
TABLE 2 - Histological grading based in the optical density
related related to the inflammatory reaction in
tissues of skin infected wounds treated with
simvastatin and saline (µm2)
Simvastatin Saline p-value
Inflammation (SIM)* (SAL)*
Inflammatory
reaction 844.7 ± 65.2 3416.1 ± 233.4 0.00001
* Mean ± Standard deviation
1 - Difference statistically significant comparing the groups SIM/
SAL (Student t test).
Image Pro-plus software Media Cybernetics was used.
Groups
FIGURE 2 - Mean areas corresponding to the expression of
IL-1β Significant difference comparing the
groups simvastatin and saline (p<0.05).
FIGURE 3 - Histological section of wound tissue taken from
a SAL group rat, demonstrating significant
neutrophil infiltration, giant cells and folicules.
HE, 100x.
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Discussion
Cutaneous wound healing is a complex process
involving blood clotting, inflammation, new tissue
formation, and finally tissue remodeling21. It is well
described at the histological level and many experimental
and clinical studies have demonstrated varied, but in most
cases beneficial, effects of exogenous substances11,12,13
on the healing process. However, the roles played by
these exogenous treatments have remained largely
unclear. HMG-CoA reductase inhibitors (statins) are used
clinically for lowering hypercholesterolemia because of
their inhibitory effect on hepatic biosynthesis of
cholesterol at the mevalonate step22. These  statins such
as simvastatin have been shown to exhibit important
immunomodulatory effects independent of lipid
lowering23 These pleiotropic effects have been
demonstrated to include anti-inflammatory actions24. The
present study is one of the first to demonstrate that
HMG-CoA reductase inhibitors significantly  improve
healing of infected skin wounds in an experimental model
in rats. The improvement in inflammatory reaction and  in
cytokines expression corroborates some results in the
literature that clearly demonstrate that simvastatin is a
potent and effective endothelium-protective agent that
reduces leukocyte–endothelial  cell  interactions
independently of its well-known lipid-lowering effects.
This effect has been found to be at least partially mediated
via downregulation of P-selectin expression on the
microvascular endothelium. Thus, HMG-CoA reductase
inhibitors like simvastatin have important anti-
inflammatory effects besides their well-known lipid-
lowering action25,26.  In the present study we
demonstrated that the topical application of simvastatin
microemulsion attenuated the inflammatory reaction in
wound healing of infected tissues, but to date the
mechanism is not clear. Prueffer et al27.demonstrated a
protective effect of simvastatin under conditions of acute
inflammation induced by an exotoxin within the
microcirculation. In particular, they provide strong
evidence that simvastatin is able to attenuate enhanced
leukocyte-endothelium interaction after S aureus  toxin
administration. Pore-forming S aureus toxin is known to
provoke  inflammatory acctivation28,29,30. These evidences
may explain hour results with the topical use of
simvastatin in the healing of infected wounds. Statins
affect the production of many acute phase reactants,
including CRP, which is produced in the liver under
stimulation by cytokines (IL-1 and IL-6).  In
nonatherosclerotic huCRP transgenic mice, statins
decreased basal and IL-1b-induced plasma huCRP levels
independently of cholesterol lowering and of an effect
on IL-6 production31 . In fact, in this work simvastatin
was able to induce a marked decrease in TNFα anf IL-1β
in healing tissues,  as demonstrated by
immunohystochemical  analysis. A probable antibacterial
effect was also observed, and the exact mechanism to
explain this action is to be described. In an other study
the pretreatment was found to decrease cytokine-
stimulated transcription factor activation and iNOS
expression in the endothelium, stating that simvastatin
affect cytokines with several ways32.
TABLE 3 - Detection of bacteria in the wound fluid of animals in groups treated with simvastatin (SIM) and treated with
saline (SAL).
Rat SIM Group / CFU/g SAL Group/ bacteria CFU/g
number bacteria
1 NBG 0 Klebsiella sp; Proteus > 100,000
Mirabilis; Proteus vulgaris;
Staphylococcus coagulase
negative
2 NBG 0 Proteus mirabilis; Escherichia 90,000
coli; Staphylococcus
coagulase negative
3 NBG 0 Proteus mirabilis; Escherichia > 100,000
coli; Staphylococcus
coagulase negative
4 Proteus mirabilis; Klebsiella sp; Proteus >100,000
Escherichia coli; 50,000 mirabilis
Enterobacter sp
5 NBG 0 Escherichia coli; Enterobacter > 100,000
sp; Proteus mirabilis
6 NBG 0 Proteus mirabilis; Escherichia > 100,000
coli
NBG, No bacterial growth; CFU/g, Colony forming unit per gram.
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Conclusion
In addition to its antiinflammatory properties, the
protective effects of simvastatin in infected open skin
wounds is able to reduce infection and probably has
antibacterial action. The potential to treat these wounds
with statins to ameliorate inflammation and infection is
promising.
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